2[1]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J]. J Immunol Methods,1983,65(1-2):55-63.
3[2]Taylor CG, Sargent JM, Elgie AW, et al. The clinical relevance of chemosensitivity testing in ovarian cancer[J]. Cancer Detect Prey,1998,22(4) :305-312.
4[3]Sargent JM. The use of the MTT assay to study drug resistance in fresh tumour samples[J]. Recent Results Cancer Res, 2003,161(1) :13-25.
5[4]Fujita K, Kubota T, Matsuzaki SW, et al. Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer[J]. Anticancer Res, 1998,18(3B) :1973-1978.
6[5]Kubota T, Egawa T, Otani Y, et al. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages Ⅲ/Ⅳ gastric cancers without peritoneal dissemination[J]. Anticancer Res, 2003,23(1B):583-587.
7[6]Tanino H, Oura S, Hoffman RM, et al. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay[J]. Anticancer Res, 2001,21 (6A) :4083-4086.
8李振，恶性肿瘤化学治疗学，1990年
9J.K wilson,J.M.Sargent,A.W.Elgie,et al,A feasibility.study of the MTT assay for chemosensitivity testing in ovarian malignancy. British Journal of Cancer . 1990
10Toshibaru Furakawa MD,Testuto Kubota MD,Akihiko Suto MD et al.Clinical usefulness.of chemosensitivity testing using the MTT assay. Journal of Surgery . 1992
